Back
Avalo Therapeutics Stock Price Chart
Big exits started like this. So did Mode
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite
Sell
36
AVTX
Avalo Therapeutics
Last Price:
$4.94
Seasonality Move:
-5.27%
7 Day Trial
ALL ACCESS PASS
$
7
From 50,000 investors to Nasdaq? Mode's next move...
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite-
The current trend is relatively stagnant and AVTX is experiencing slight buying pressure.
Avalo Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.23 | Buy |
| 20-day SMA: | 3.98 | Buy |
| 50-day SMA: | 4.79 | Sell |
| 200-day SMA: | 8.05 | Sell |
| 8-day EMA: | 4.24 | Buy |
| 20-day EMA: | 4.21 | Buy |
| 50-day EMA: | 4.88 | Sell |
| 200-day EMA: | 15.53 | Sell |
Avalo Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 54.83 | Buy |
| Chaikin Money Flow: | 92342 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.72 - 4.46) | Buy |
| Bollinger Bands (100): | (4.55 - 7.81) | Sell |
Avalo Therapeutics Technical Analysis
| May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Avalo Therapeutics Stock
Is Avalo Therapeutics Stock a Buy?
-
Avalo Therapeutics share price is 4.56 while AVTX 8-day simple moving average is 4.23, which is a Buy signal.
-
The stock price of AVTX is 4.56 while Avalo Therapeutics 20-day SMA is 3.98, which makes it a Buy.
-
Avalo Therapeutics 50-day simple moving average is 4.79 while AVTX share price is 4.56, making it a Sell technically.
-
AVTX stock price is 4.56 and Avalo Therapeutics 200-day simple moving average is 8.05, creating a Sell signal.
AVTX Technical Analysis vs Fundamental Analysis
Sell
36
Avalo Therapeutics (AVTX)
is a Sell
Is Avalo Therapeutics a Buy or a Sell?
-
Avalo Therapeutics stock is rated a SellThe current Avalo Therapeutics [AVTX] share price is $4.56. The Score for AVTX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
Avalo Therapeutics Stock Info
Market Cap:
49.4M
Price in USD:
4.56
Share Volume:
197.4K
Avalo Therapeutics 52-Week Range
52-Week High:
16.00
52-Week Low:
3.39
Sell
36
Avalo Therapeutics (AVTX)
is a Sell
Avalo Therapeutics Share Price Forecast
-
What is the Avalo Therapeutics stock price today?The Avalo Therapeutics stock price is 4.56 USD today.
-
Will AVTX stock go up or go down?Avalo Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Avalo Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Avalo Therapeutics is overvalued.
Is Avalo Therapeutics Stock a Buy?
-
Avalo Therapeutics share price is 4.56 while AVTX 8-day exponential moving average is 4.24, which is a Buy signal.
-
The stock price of AVTX is 4.56 while Avalo Therapeutics 20-day EMA is 4.21, which makes it a Buy.
-
Avalo Therapeutics 50-day exponential moving average is 4.88 while AVTX share price is 4.56, making it a Sell technically.
-
AVTX stock price is 4.56 and Avalo Therapeutics 200-day simple moving average is 15.53, creating a Sell signal.
Fundamental Analysis of Avalo Therapeutics
Is Avalo Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $2.91 per share, a decrease next quarter of $0.88 per share, a decrease this year of $17.29 per share, and an increase next year of $0.21 per share.
Technical Analysis of Avalo Therapeutics
Should I short Avalo Therapeutics stock?
-
AVTX Moving Average Covergence Divergence (MACD) indicator is -0.13, suggesting Avalo Therapeutics is a Sell
-
Avalo Therapeutics Relative Strength Index (RSI) is 54.83, which suggest Avalo Therapeutics is overbought
-
The Bollinger Bands (25) for Avalo Therapeutics is (3.72 - 4.46), which suggest Avalo Therapeutics is a Sell
-
The Bollinger Bands (100) for Avalo Therapeutics is (4.55 - 7.81), which suggest Avalo Therapeutics is a Sell
* Avalo Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.